Show simple item record

dc.contributor.authorVillar, Adriany
dc.creatorVillar, Adriany
dc.date.accessioned2021-12-09T16:19:31Z
dc.date.available2021-12-09T16:19:31Z
dc.date.issued2021-12-13
dc.identifier.urihttp://hdl.handle.net/20.500.13013/2178
dc.description.abstractIn the real world, how medications are prescribed and taken by patients differs from a patient enrolled in clinical trials. For example, medications may be given to patients with disease severity ranging from mild to very severe, who have comorbidities, and who have variable adherence to the treatment regimen. After a drug is licensed and on the market, comparative effectiveness studies are conducted with real world data to assure that the drugs remain effective when used by real world patients. CorEvitas conducts comparative effectiveness research among cohorts of patients enrolled in the Rheumatoid Arthritis Registry. This poster presents the design of an observational cohort study, including study protocols.
dc.subjectHealthcare Studies
dc.titleAdult Rheumatoid Arthritis: Evaluating Treatment Effectiveness Among Patients
dc.typeevent
dc.contributor.sponsorEveritt, Amy
dc.date.displayDecember 13, 2021en_US
dc.date.displayDecember 13, 2021
dc.subject.keywordauto immune
dc.subject.keyworddisease
dc.subject.keywordepidemiology
dc.subject.keywordrheumatoid arthritis
dc.subject.keywordPROs
dc.subject.keywordresearch


Files in this item

Thumbnail
Name:
villar-adriany-poster.pdf
Size:
766.1Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record